Privium Fund Management B.V.
Position in ESPR — Esperion Therapeutics, Inc.
CIK 1795097
AMSTERDAM, P7
Position in ESPR
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$0
New position
Shares Held
3,299,441
first reported quarter
Ownership
1.28%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Privium Fund Management B.V. holds $4,018,358 across 2 Drug Manufacturers - Specialty & Generic names.
All Filings in ESPR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 3,299,441 | Shares | Sole | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||